Phase 2b Challenge Study With the Bioconjugate Vaccine Flexyn2a

NCT02646371 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

67

Enrollment

INDUSTRY

Sponsor class

Conditions

Shigellosis

Interventions

BIOLOGICAL: Flexyn2a
BIOLOGICAL: Placebo

Sponsor

LimmaTech Biologics AG

Collaborators

[object Object]